Evidence map›Paper›PMID 41691094›Full record

ArticleBone marrow transplantation2026

Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy.

Yu Yagi, Yusuke Kanemasa, Hideki Goto, Masahide Yamamoto, Kotaro Miyao, Maki Hagihara, Toshio Kitawaki, Tatsu Shimoyama, Ryo Hanajiri, Shinichi Makita and 13 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Yu YagiDepartment of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. yyagi1068@gmail.com.ORCID http://orcid.org/0009-0001-9372-9911
Yusuke KanemasaDepartment of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Hideki GotoDepartment of Hematology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.
Masahide YamamotoDepartment of Hematology, Institute of Science Tokyo Hospital, Tokyo, Japan.
Kotaro MiyaoDepartment of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.ORCID http://orcid.org/0000-0003-0716-1424
Maki HagiharaDepartment of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan.
Toshio KitawakiDepartment of Hematology, Kyoto University Hospital, Kyoto, Japan.ORCID http://orcid.org/0000-0002-6373-3442
Tatsu ShimoyamaDepartment of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Ryo HanajiriDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0002-6034-7909
Shinichi MakitaDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6609-8088
Go YamamotoDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Masatoshi SakuraiDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Nobuharu FujiiDepartment of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Takahide AraDepartment of Hematology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.ORCID http://orcid.org/0000-0001-9609-3202
Yasuhiro NakashimaHematology and Hematopoietic Cell Transplantation, Osaka Metropolitan University Hospital, Osaka, Japan.ORCID http://orcid.org/0000-0003-3025-723X
Akiyo YoshidaDivision of Transfusion Medicine, Kanazawa University Hospital, Ishikawa, Japan.
Hideyuki NakazawaDepartment of Hematology and Clinical Oncology, Shinshu University School of Medicine, Matsumoto, Japan.
Emiko SakaidaDepartment of Hematology, Chiba University Hospital, Chiba, Japan.ORCID http://orcid.org/0000-0002-7254-1928
Nobuhiro KanemuraDepartment of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.ORCID http://orcid.org/0000-0001-8449-9918
Haryoon KimDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Keisuke KataokaDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0009-0006-7339-9800
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.ORCID http://orcid.org/0000-0003-4404-2870
Koji KatoDepartment of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41691094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.